Madrigal Pharmaceuticals, Inc. Common Stock
Symbol: MDGL (NASDAQ)
417.07
▼ (-3.01%) -12.930
Company Description:
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.
Key Stats
- Today's Open: $426.57
- Today's High: $437.5
- Today's Low: $414.365
- Today's Volume: 177.24K
- Yesterday Close: $430
- Yesterday High: $445.0608
- Yesterday Low: $427.06
- Yesterday Volume: 249.80K
- Last Min Volume: 1.15K
- Last Min High: $417.132
- Last Min Low: $416.94
- Last Min VWAP: $416.9626
Company Profile
- Name: Madrigal Pharmaceuticals, Inc. Common Stock
- Website: https://www.madrigalpharma.com
- Listed Date: 2007-02-06
- Location: WEST CONSHOHOCKEN, PA
- Market Status: Active
- CIK Number: 0001157601
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $9.58B
- Round Lot: 100
- Outstanding Shares: 22.29M
- Asset Type: CS
RECENT FILINGS FOR MDGL
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-11 | S-8 | View |
| 2025-09-09 | 144 | View |
| 2025-09-09 | 4 | View |
| 2025-08-29 | 144 | View |
| 2025-08-21 | 4 | View |
| 2025-08-21 | 144 | View |
| 2025-08-20 | 4 | View |
| 2025-08-20 | 4 | View |
| 2025-08-20 | 144 | View |
| 2025-08-18 | 4 | View |
| 2025-08-18 | 144 | View |
| 2025-08-18 | 144 | View |
| 2025-08-15 | 4 | View |
| 2025-08-15 | 144 | View |
| 2025-08-15 | 144 | View |
| 2025-08-14 | SCHEDULE 13G/A | View |
| 2025-08-13 | 4 | View |
| 2025-08-13 | 4 | View |
| 2025-08-13 | 4 | View |
| 2025-08-13 | 144 | View |
Latest News on MDGL